Skip to main content
logo
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.380
0.00 (0.00%)
At close: Apr 1, 2026, 4:00 PM EDT
1.370
-0.010 (-0.72%)
After-hours: Apr 1, 2026, 5:43 PM EDT

Autolus Therapeutics Revenue

In the year 2025, Autolus Therapeutics had annual revenue of $75.39M with 644.94% growth. Autolus Therapeutics had revenue of $24.29M in the quarter ending December 31, 2025, with 83,655.17% growth.

Revenue (ttm)
$75.39M
Revenue Growth
+644.94%
P/S Ratio
4.85
Revenue / Employee
$115,982
Employees
650
Market Cap
367.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202575.39M65.27M644.94%
Dec 31, 202410.12M8.42M496.00%
Dec 31, 20231.70M-4.66M-73.30%
Dec 31, 20226.36M4.03M172.96%
Dec 31, 20212.33M615.00K35.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ginkgo Bioworks Holdings170.16M
Enanta Pharmaceuticals66.98M
Invivyd53.43M
XOMA Royalty52.15M
X4 Pharmaceuticals35.11M
Armata Pharmaceuticals4.90M
Revenue Rankings

AUTL News

More News